ArticleCase reports in oncology

Long-Term Complete Response to Pembrolizumab in Tumor Mutation Burden-High Small Cell Lung Cancer: A Case Report.

Kiyohide Komuta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.